4//SEC Filing
CHASE WILLIAM J 4
Accession 0000899243-23-011381
CIK 0001652130other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:04 PM ET
Size
7.3 KB
Accession
0000899243-23-011381
Insider Transaction Report
Form 4
CHASE WILLIAM J
Director
Transactions
- Award
Common Stock
2023-04-14+10,483→ 17,283 total - Award
Stock Option (Right to Buy)
2023-04-14+14,931→ 14,931 totalExercise: $38.16Exp: 2033-04-13→ Common Stock (14,931 underlying)
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on April 14, 2023 with respect to 14,931 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3 % vesting on April 14, 2024 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001563572
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 5:04 PM ET
- Size
- 7.3 KB